Poniard Pharmaceuticals

(OTC) PARD

Current Price$0.00

Market Cap$100.00

Since IPO (1988)-100%

5 Year-100%

1 Year-1%

1 Month+0%

Poniard Pharmaceuticals Financials at a Glance

Market Cap

$100.00

Revenue (TTM)

$0.00

Net Income (TTM)

-$16.04M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-399.26 (Low)

Dividend

$0.00

Beta (Volatility)

-399.26 (Low)

Price

$0.00

Volume

2,625

Open

$0.00

Price

$0.00

Volume

2,625

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Feb 26, 2025

Dividend

$0.00

Beta (Volatility)

-399.26 (Low)

Price

$0.00

Volume

2,625

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Feb 26, 2025

PARD News

10 Stocks to Shake the Market

Rich DupreyJul 9, 2009

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Poniard Pharmaceuticals

Industry

Biotechnology

Sector

Health Care

Headquarters

Seattle, WA 98119, US

PARD Financials

Key Financial Metrics (TTM)

Gross Margin

0.00%

Operating Margin

0.00%

Net Income Margin

0.00%

Return on Equity

-187.25%

Return on Capital

-278.83%

Return on Assets

-258.10%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$100.00

Shares Outstanding

1.50M

Volume

2.63K

Avg. Volume

49.387

Financials (TTM)

Gross Profit

$0.00

Operating Income

-$15.53M

EBITDA

-$14.26M

Operating Cash Flow

-$10.46M

Capital Expenditure

-$9.00K

Free Cash Flow

-$10.47M

Cash & ST Invst.

$1.98M

Total Debt

$1.64M

Poniard Pharmaceuticals Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q3 2011YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$100.00

N/A

Market Cap/Employee

$14.29

N/A

Employees

N/A

Net Income

-$3.77M

+41.5%

EBITDA

-$3.44M

+38.9%

Quarterly Fundamentals

Name

Q3 2011YOY CHG

Total Cash

$1.98M

-91.5%

Total Debt

$1.64M

-88.7%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$1.64M

-75.1%

Short Term Debt

$0.00

-100.0%

Return on Assets

-2.58%

N/A

Return on Invested Capital

-2.79%

N/A

Free Cash Flow

-$1.71M

+56.0%

Operating Cash Flow

-$1.71M

+55.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

XSNXNovAccess Global Inc.

XSNXNovAccess Global Inc.$0.00+0.00%

RCARRenovaCare, Inc.

RCARRenovaCare, Inc.$0.00+0.00%

QBIOQ BioMed Inc.

QBIOQ BioMed Inc.$0.00-0.00%

VOQPVioQuest Pharmaceuticals, Inc.

VOQPVioQuest Pharmaceuticals, Inc.$0.00+0.00%

AOLSAeolus Pharmaceuticals, Inc.

AOLSAeolus Pharmaceuticals, Inc.$0.00+0.00%

RGINRegenicin, Inc.

RGINRegenicin, Inc.$0.00+0.00%

SCPSScopus BioPharma Inc.

SCPSScopus BioPharma Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.92-0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.30-0.15%

CLROClearOne

CLROClearOne$6.48+1.01%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$73.35-0.05%

ONDSOndas

ONDSOndas$7.41-0.06%

SOFISoFi Technologies

SOFISoFi Technologies$18.24-0.01%

NOKNokia

NOKNokia$12.07-0.07%

Questions About PARD

What is the current price of Poniard Pharmaceuticals?

Poniard Pharmaceuticals is trading at $0.00 per share.

What is the 52-week range for Poniard Pharmaceuticals?

Over the past 52 weeks, Poniard Pharmaceuticals has traded between $0.00 and $0.00.

How much debt does Poniard Pharmaceuticals have?

Poniard Pharmaceuticals total debt is unavailable.

How much cash does Poniard Pharmaceuticals have on hand?

Poniard Pharmaceuticals does not have cash on hand data available.

What is Poniard Pharmaceuticals’s dividend yield?

Poniard Pharmaceuticals does not currently have a dividend yield.

Poniard Pharmaceuticals

Poniard Pharmaceuticals Financials at a Glance

PARD News

10 Stocks to Shake the Market

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Poniard Pharmaceuticals

PARD Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Poniard Pharmaceuticals Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About PARD

What is the current price of Poniard Pharmaceuticals?

What is the 52-week range for Poniard Pharmaceuticals?

How much debt does Poniard Pharmaceuticals have?

How much cash does Poniard Pharmaceuticals have on hand?

What is Poniard Pharmaceuticals’s dividend yield?

Premium Investing Services